BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/MAPK6/Compounds

Compounds That Target MAPK6

mitogen-activated protein kinase 6 · 10 compounds in BiohacksAI corpus

MAPK6 (mitogen-activated protein kinase 6) is a biological target with 10 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MAPK6 modulation for therapeutic and biohacking applications.

View MAPK6 target page →UniProt: Q16659 ↗
Most Studied Compounds for MAPK6
1
Crizotinib
298+
studies
All 10 Compounds — Ranked by Evidence
1
Gefitinib
5.67
confidence
2
Vandetanib
4.30
confidence
3
Canertinib
3.53
confidence
4
Bms 387032
3.47
confidence
5
Fedratinib
3.40
confidence
6
Jnj 7706621
3.09
confidence
7
Bms 345541
2.71
confidence
8
Kw 2449
2.64
confidence
9
Ravoxertinib
2.08
confidence
10
Crizotinib
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MAPK6 (mitogen-activated protein kinase 6). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MAPK6 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.